| Louis J Scallon, MD | |
|
2020 Philadelphia St, Ames, IA 50010-8772 | |
| (515) 232-2450 | |
| (515) 232-3532 |
| Full Name | Louis J Scallon |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 2020 Philadelphia St, Ames, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497747299 | NPI | - | NPPES |
| 180027519 | Other | IA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 26457 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Louis J Scallon, MD 309 E Church St, Marshalltown, IA 50158-2946 Ph: (641) 754-6200 | Louis J Scallon, MD 2020 Philadelphia St, Ames, IA 50010-8772 Ph: (515) 232-2450 |
News Archive
Researchers at the Johns Hopkins Bloomberg School of Public Health have identified a gene in the Anopheles gambiae mosquito's DNA that is central to the insect's ability to defend against infectious pathogens, including Plasmodium, the parasite that causes malaria in humans.
Aura Biosciences, Inc., a biotech company focused on the development of nano-enabled drug delivery systems, has completed several pre-clinical research programs. The resulting data suggest that Aura's NanoSmart platform can enable earlier detection of cancers and distant metastases; and then provide precisely targeted treatment of those cancers.
CytRx Corporation, a biopharmaceutical company specializing in oncology, announces progress with its clinical program to evaluate the preliminary efficacy and safety of its drug candidate bafetinib in three oncology indications. The Company has enrolled its first patient in a Phase 2 proof-of-concept trial in patients with high-risk B-cell chronic lymphocytic leukemia (B-CLL), is reporting rapid advancement toward the initiation of a Phase 2 proof-of-concept trial in advanced prostate cancer, and is on track to begin clinical evaluation later this year in glioblastoma multiforme, a common and aggressive type of primary brain tumor.
Surgeons at UC San Diego Health System have performed the region's first robotic gastrectomy, a potentially lifesaving procedure to remove a section of the stomach after a diagnosis of gastric cancer. Aided by a da Vinci robot, surgeons remove the diseased tissue, perform a delicate reconstruction and remove local lymph nodes for further testing.
› Verified 9 days ago
Dr. Linda Jane Lehman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1128 Duff Ave, Ames, IA 50010 Phone: 515-239-4460 Fax: 515-956-4145 | |
Daniel J Vos, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2020 Philadelphia St, Ames, IA 50010 Phone: 515-232-2450 | |
Dr. Kenneth Earl Talbert, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1128 Duff Ave, Ames, IA 50010 Phone: 515-239-4460 Fax: 515-239-4437 | |
Ryan David Vincent, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Philadelphia St, Ames, IA 50010 Phone: 515-232-2450 Fax: 515-232-3532 | |
Tracy Anne Kangas, MD PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1128 Duff Avenue, Mcfarland Clinic Pc, Ames, IA 50010 Phone: 515-239-4460 Fax: 515-956-4145 | |
Dr. Nicolas George Hamouche, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1128 Duff Ave, Ames, IA 50010 Phone: 515-663-4888 Fax: 515-956-4199 |